Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: We compared surgical device malfunction reports in the Food and Drug Administration (FDA) public Manufacturer and User Facility Device Experience (MAUDE) with those in the FDA nonpublic Alternative Summary Reporting (ASR).

Methods: General surgery device product code categories in MAUDE and ASR from 1999 to 2018 were identified. Changes in the rates of categories and adverse events were evaluated by Poisson regression.

Results: There were 283,308 (72%) general surgical device malfunctions in MAUDE and 109,954 (28%) in ASR. Reports increased annually in ASR versus MAUDE, particularly for surgical staplers and clip devices (p < 0.05). ASR contained approximately 80% of these reports; MAUDE 20%. In MAUDE, 42.9% of surgical device malfunctions and 20.2% of stapler/clip malfunctions resulted in patient injury or death. ASR listed no injury or death information.

Conclusions: ASR contained a significant portion of surgical device malfunctions hidden from public scrutiny. Access to such data is essential to safe surgical care.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2021.03.017DOI Listing

Publication Analysis

Top Keywords

surgical device
12
device malfunctions
8
food drug
8
drug administration
8
device
6
revealing scope
4
surgical
4
scope surgical
4
malfunctions analysis
4
analysis "hidden"
4

Similar Publications

Introduction: Pulmonary embolism (PE) is a life-threatening condition with well-defined management strategies; however, the presence of a clot-in-transit (CIT)-a mobile thrombus within the right heart-introduces a uniquely high-risk scenario associated with a significantly elevated mortality rate. While several therapeutic approaches are available-including anticoagulation, systemic thrombolysis, surgical embolectomy, and catheter-directed therapies-there is no established consensus on a superior treatment modality. Catheter-based mechanical thrombectomy has emerged as a promising, minimally invasive alternative that mitigates the bleeding risks of systemic thrombolysis and the invasiveness of surgery.

View Article and Find Full Text PDF

Background: The incidence of cancer therapy-related cardiac dysfunction is increasing with the growing number of breast cancer patients. In particular, patients with active cancer combined with severe irreversible cardiac dysfunction present significant challenges in treatment decision-making.

Case Summary: A 40-year-old woman with Stage II HER-2-positive breast cancer received anthracycline followed by HER2-targeted agents.

View Article and Find Full Text PDF

Tuberous breast deformity in a transgender woman: a case report.

J Surg Case Rep

September 2025

Division of Plastic and Reconstructive Surgery, University of California, Los Angeles, 200 Medical Plaza, Suite 460, Los Angeles, CA 90095, United States.

Tuberous breast deformity was first documented by Rees and Aston in 1976. The deformity is well documented in cisgender women, with rare cases in cisgender men often associated with gynecomastia, and almost no reports in transgender women. Herein, we present a case of a 32-year-old transgender woman who developed bilateral tuberous breast deformity after 10 years of hormone replacement therapy.

View Article and Find Full Text PDF

Laparoscopic cryptorchidectomy in 10 equids using a single incision laparoscopic surgery (SILS) port device.

Can Vet J

September 2025

Department of Clinical Studies, Ontario Veterinary College, University of Guelph, 50 Stone Road East, Guelph, Ontario N1G 2W1.

Minimally invasive laparoscopic surgical techniques are desirable in horses and other equids. A new approach called "modified single incision laparoscopic surgery (SILS) for equine cryptorchidectomy" is described, along with the postoperative outcomes of 10 equids. A SILS Port device (Covidien) was placed a 30- to 40-millimeter incision in combination with 1 or 2 15-millimeter para-inguinal incisions to exteriorize the intra-abdominal testicles.

View Article and Find Full Text PDF

Use of a masseter fascia transposition flap for ventral orbital stabilization after partial inferior orbitectomy in a dog.

Can Vet J

September 2025

Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, 1800 Denison Avenue, Manhattan, Kansas 66506, USA.

A 12-year-old neutered male pit bull crossbreed dog was presented because of a right caudal maxillary swelling. Computed tomographic imaging of the skull and revealed a right maxillary mass with lysis of the medial wall of the right orbit and rostral aspect of the zygomatic bone. A biopsy was done, and histopathology results were consistent with a mixed odontogenic tumor.

View Article and Find Full Text PDF